ARCHIVES

NMP22 Assay More Effective Than Conventional Lab Test

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Cech To Step Down At HHMI In 2009.

April 18, 2008

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000